Keragon key facts
as of Oct 2026- Operator of a healthcare integration and automation platform intended to simplify and automate healthcare workflows.
- Keragon is valued at approximately $32.0M as of Oct 2026 (last reported valuation).
- It has raised $10.5M; the latest was Seed Round ($7.5M) in Feb 2025.
- Notable investors include Afore Capital, Upfront Ventures, Endeavor Greece, 25madison, Focal (VC) — 9 tracked in total.
- Status: Privately Held (backing).
Keragon's last reported valuation, Feb 2025. Nothing priced has surfaced since.
- ·Watch Keragon: the Monday email on marks, rounds and moves
Keragon funding rounds
No funding rounds for Keragon are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Keragon valuation
Keragon's last reported valuation was $32 million in Feb 2025. No priced round, secondary trade or fund mark has surfaced since.
Keragon investors
9 investors are on record for Keragon, including Afore Capital, Upfront Ventures, Endeavor Greece and 25madison.
About Keragon
Operator of a healthcare integration and automation platform intended to simplify and automate healthcare workflows. The company allows healthcare organizations to connect their disparate systems and automate common tasks, such as appointment scheduling, healthcare customer relation management, AI medical scribes, patient intake, and billing, enabling healthcare product teams to improve efficiency, reduce costs, and improve patient care.
- Sector
- Information Technology
- HQ
- Boston, MA, United States
- Founded
- 2022
- Employees
- 22
- Website
- keragon.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.